Company Portfolio
Curevac AG
Patents indexed
2
biotechpharmaceuticaloncologygene_editing
All Patents
2
US 20160166668
How an mRNA Vaccine Targets Prostate Cancer with Six Antigens
This patent describes an mRNA vaccine designed to treat prostate cancer by delivering genetic instructions for a specific combination of six prostate-related proteins, teaching the body to fight the cancer.
US 20160168227· INDEXING
Composition and vaccine for treating lung cancer
Patent monitoring